There is no cure for Alzheimer's disease and death usually occurs within ten years of diagnosis, so the best option now is to prevent it early.
The collaboration aims to improve the efficiency of the drug discovery pipeline by leveraging industry-leading capabilities to identify genetic variants that cause human disease.